HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

HA-1 antigen

mismatching of this antigen corresponds to severe graft versus host disease after human leukocyte antigen-identical bone marrow transplantation
Also Known As:
VLHDDLLEA; Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala; mHag HA-1; valyl-leucyl-histidyl-aspartyl-aspartyl-leucyl-leucyl-glutamyl-alanine
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Goulmy, Els: 3 articles (03/2009 - 01/2003)
2. Hambach, Lothar: 2 articles (03/2009 - 09/2008)
3. Aghai, Zohara: 2 articles (03/2009 - 09/2008)
4. Pool, Jos: 2 articles (03/2009 - 01/2003)
5. van Boven, Hester: 1 article (03/2009)
6. Blokland, Els: 1 article (03/2009)
7. Tanke, Hans J: 1 article (03/2009)
8. Bruijn, Jan A: 1 article (03/2009)
9. Halfwerk, Hans: 1 article (03/2009)
10. Ling, Kam-Wing: 1 article (03/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Graft vs Host Disease (Graft-Versus-Host Disease)
3. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. Histocompatibility Antigens (Histocompatibility Antigen)
2. Antigens
3. Interferon-gamma (Interferon, gamma)

Related Therapies and Procedures

1. Hematopoietic Stem Cell Transplantation
2. Bone Marrow Transplantation (Transplantation, Bone Marrow)
3. Immunotherapy